RECORD // Company

AbbVie Inc.

Built 2026-11-22T00:33:18Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (66 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (65)
SEC EDGAR (1)
  • AbbVie Inc. · the SEC registrant record of this company
Matched by name only, not merged (45)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • AbbVie · Breach states · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie · Breach states · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie Inc. · Breach states · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie Inc. · Breach states · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie, Inc. (The Lash Group, LLC) · Breach states · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE US LLC · Brla parish businesses · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie Inc. · Ca breach · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC · Ca business · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Abbvie Inc · Ca business · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Abbvie Inc · Ca business · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Abbvie Inc · Ca business · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Abbvie Us LLC · Ca business · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE US LLC · Ca payments · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC. · Ct business · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE US LLC · Ct business · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie · Ctgov · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie (prior sponsor, Abbott) · Ctgov · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC · East licences · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC · East licences · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC · East licences · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC. · East licences · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE LTD · East licences · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE US · East licences · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE US LLC · East licences · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE US LLC · East licences · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE US LLC · East licences · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE US LLC · East licences · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE US LLC · East licences · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie Biotechnology LTD. · East licences · same registered legal name as a GLEIF subsidiary (LEI 54930060NJXJDDYP5569) Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie Deutschland GmbH & Co. KG · East licences · same registered legal name as a GLEIF subsidiary (LEI 549300FI0P3XDOCBXJ78) Possible match based on name, not a shared identifier. Compare the records. Compare
  • AbbVie Ireland NL B.V. · East licences · same registered legal name as a GLEIF subsidiary (LEI 549300ZNKHBEKHCOHJ43) Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE · Epa echo · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE · Epa echo · name equals 'Abbvie' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC · Epa echo · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC · Epa echo · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC · Epa echo · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC · Epa echo · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE INC. · Epa echo · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE LTD · Epa echo · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ABBVIE, INC. · Epa echo · same registered legal name as 'AbbVie Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

10 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-03 · accession 0001551152-26-000037

ItemValuePeriodFormFiledAccessionReport
Revenue$17,404,000,0003 months ended 2026-09-3010-Q2026-11-030001551152-26-0000372026-11-22 00:33 UTCReport an error
Net income (loss)$4,218,000,0003 months ended 2026-09-3010-Q2026-11-030001551152-26-0000372026-11-22 00:33 UTCReport an error
Interest expense$802,000,0003 months ended 2026-09-3010-Q2026-11-030001551152-26-0000372026-11-22 00:33 UTCReport an error
Cash and cash equivalents$10,774,000,000at 2026-09-3010-Q2026-11-030001551152-26-0000372026-11-22 00:33 UTCReport an error
Debt due in the next 12 months (from an earlier report)$6,000,000,000at 2025-12-3110-K2026-02-200001551152-26-0000082026-11-22 00:33 UTCReport an error
Debt due in year 2 (from an earlier report)$5,130,000,000at 2025-12-3110-K2026-02-200001551152-26-0000082026-11-22 00:33 UTCReport an error
Debt due in year 3 (from an earlier report)$4,466,000,000at 2025-12-3110-K2026-02-200001551152-26-0000082026-11-22 00:33 UTCReport an error
Debt due in year 4 (from an earlier report)$8,645,000,000at 2025-12-3110-K2026-02-200001551152-26-0000082026-11-22 00:33 UTCReport an error
Debt due in year 5 (from an earlier report)$1,000,000,000at 2025-12-3110-K2026-02-200001551152-26-0000082026-11-22 00:33 UTCReport an error
Debt due after year 5 (from an earlier report)$39,262,000,000at 2025-12-3110-K2026-02-200001551152-26-0000082026-11-22 00:33 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001551152
Ticker
ABBV
EIN
320375147
UEI
VAFXUGJBLML4
CUSIP
00287Y109
Record ID
sx:sec:0001551152

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

45 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-18SEC EDGAR company profile2026-11-22 00:33 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-18SEC EDGAR company profile2026-11-22 00:33 UTCReport an error
State of incorporationDE2026-11-18SEC EDGAR company profile2026-11-22 00:33 UTCReport an error
Fiscal year end (MMDD)12312026-11-18SEC EDGAR company profile2026-11-22 00:33 UTCReport an error
Business address1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 600642026-11-18SEC EDGAR company profile2026-11-22 00:33 UTCReport an error
ExchangesNYSE2026-11-18SEC EDGAR company profile2026-11-22 00:33 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$61,160,000,0002025-12-3110-K, XBRL Revenues2026-11-22 00:33 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$4,226,000,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:33 UTCReport an error
Total assets (at 2025-12-31)$133,960,000,0002025-12-3110-K, XBRL Assets2026-11-22 00:33 UTCReport an error
Stockholders' equity (at 2025-12-31)$-3,270,000,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:33 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$5,229,000,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:33 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$19,030,000,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:33 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$1,214,000,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:33 UTCReport an error
Long-term debt (at 2025-12-31)$64,503,000,0002025-12-3110-K, XBRL LongTermDebt2026-11-22 00:33 UTCReport an error
Operating lease liabilities (at 2025-12-31)$883,000,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:33 UTCReport an error
8-K Item 5.02 (filed 2026-11-02)Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On October 28, 2026, Jennifer L. Davis, a Class II director of AbbVie Inc. (“AbbVie”), notified the Company’s Board of Directors (the “Board”), of her intent to resign from the Board, effective November 2, 2026, in light of her recent appointment as Chief Executive Officer at Align Technology, Inc. Her resignation as a director is not the result of any dispute or disagreement with AbbVie on any matter relating to the operations, policies or practices of AbbVie.2026-11-02SEC EDGAR 8-K 0001104659-26-121322 (text as filed, excerpt)2026-11-22 00:33 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-10-30)On October 30, 2026, AbbVie Inc. issued a press release announcing financial results for the third quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.2026-10-30SEC EDGAR 8-K 0001551152-26-000033 (text as filed, excerpt)2026-11-22 00:33 UTCReport an error
8-K Item 5.02, Departure of Directors or Certain Officers; Election (filed 2026-10-15)of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On October 14, 2026, AbbVie Inc. (“AbbVie”) expanded the size of its Board of Directors (the “Board”) from twelve directors to thirteen directors and appointed Dr. John M. Carethers as a Class II director. Dr. Carethers currently serves as the Vice Chancellor for Health Sciences at the University of California San Diego and was previously a director of Avantor, Inc. Dr. Carethers has been appointed to the Public Policy and Sustainability Committee of AbbVie. The Board affirmatively determined that Dr. Carethers is an “independent director” under each of the standards set forth in section 303A.02 of…2026-10-15SEC EDGAR 8-K 0001104659-26-116227 (text as filed, excerpt)2026-11-22 00:33 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-10-05)Reported GAAP earnings and adjusted non-GAAP earnings for the third quarter of 2026 are expected to include acquired IPR&D and milestones expense of $216 million on a pre-tax basis, representing an unfavorable impact of $0.11 to both GAAP diluted earnings per share and adjusted non-GAAP diluted earnings per share. Results for the quarter ended September 30, 2026 have not been finalized and are subject to our financial statement closing procedures. There can be no assurance that our final results will not differ from these preliminary estimates. While acquired IPR&D and milestones expense may be incurred upon execution of collaborations, licensing agreements, and other asset acquisitions…2026-10-05SEC EDGAR 8-K 0001551152-26-000030 (text as filed, excerpt)2026-11-22 00:33 UTCReport an error
Employer name (as filed)AbbVie Inc.2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:33 UTCReport an error
Certified LCAs902026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:33 UTCReport an error
Certified LCAs later withdrawn32026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:33 UTCReport an error
Total worker positions on certified LCAs902026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:33 UTCReport an error
Top job titles (title, LCA count)Senior Statistician, Research (3); Senior Scientist I (3); Senior Statistician (3); Senior Engineer, Technology I (2); Pharmacometrician (2)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:33 UTCReport an error
Wage offered, annualized (n, min, median, max)median $139,494 (range $85,387-$346,000, 90 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:33 UTCReport an error
Worksite statesAZ; CA; GA; IL; MA; MN; NJ; WA2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:33 UTCReport an error
Plan (pension, plan no. 001)ABBVIE SAVINGS PLAN: 40,182 participants, assets $15,952,348,7252025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:33 UTCReport an error
Plan (pension, plan no. 002)ABBVIE PENSION PLAN: 20,126 participants, assets $6,027,490,1332025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:33 UTCReport an error
Plan (pension, plan no. 003)ABBVIE PENSION PLAN FOR FORMER BASF AND FORMER SOLVAY EMPLOYEES: 1,837 participants, assets $487,971,1232025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:33 UTCReport an error
Plan (other, plan no. 004)ABBVIE PENSION PLAN TRUST: n/a participants, assets $6,520,045,1992025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:33 UTCReport an error
Plan (pension, plan no. 005)LEGACY ALLERGAN RETIREMENT SAVINGS 401(K) PLAN (FOR LEGACY ALLERGAN PR EMPLOYEES): 27 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:33 UTCReport an error
Plan (welfare, plan no. 501)ABBVIE WELFARE BENEFITS PLAN: 29,064 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:33 UTCReport an error
Plan (welfare, plan no. 506)ABBVIE RETIREE WELFARE BENEFITS PLAN: 5,172 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:33 UTCReport an error
Largest institutional holder #1 (13F as filed): BlackRock, Inc.$37,617,263,9932026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Largest institutional holder #2 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$29,038,274,1012026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Largest institutional holder #3 (13F as filed): STATE STREET CORP$20,784,645,6672026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Largest institutional holder #4 (13F as filed): VANGUARD PORTFOLIO MANAGEMENT LLC$12,199,002,9132026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Largest institutional holder #5 (13F as filed): JPMORGAN CHASE & CO$12,171,988,2692026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Largest institutional holder #6 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$11,805,227,3572026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Largest institutional holder #7 (13F as filed): Capital Research Global Investors$7,574,798,4072026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Largest institutional holder #8 (13F as filed): NORGES BANK$6,430,543,9422026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Largest institutional holder #9 (13F as filed): BANK OF AMERICA CORP /DE/$5,344,270,9762026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Largest institutional holder #10 (13F as filed): FMR LLC$5,227,515,4712026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:33 UTCReport an error
Federal award transactions, fiscal year 2026 (this one registration only)$-1,464,9272026-09-30USAspending recipient profile2026-11-22 00:33 UTCReport an error
Number of federal award transactions, fiscal year 2026 (this one registration only)1812026-09-30USAspending recipient profile2026-11-22 00:33 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.